{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:33:11Z","timestamp":1776317591511,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008173","name":"Intermountain Research and Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008173","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.chest.2019.04.093","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T02:57:16Z","timestamp":1557284236000},"page":"843-851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Antibiotic Use and Outcomes After Implementation of the Drug Resistance in Pneumonia Score in ED Patients With Community-Onset Pneumonia"],"prefix":"10.1016","volume":"156","author":[{"given":"Brandon J.","family":"Webb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Mecham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Whitney","family":"Buckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Al","family":"Jephson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan C.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.chest.2019.04.093_bib1","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archinternmed.2009.259","article-title":"Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules","volume":"169","author":"McCabe","year":"2009","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.chest.2019.04.093_bib2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"ATS\/IDSA","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2019.04.093_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/cid\/cit734","article-title":"Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis","volume":"58","author":"Chalmers","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.chest.2019.04.093_bib4","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1128\/AAC.02582-14","article-title":"Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia","volume":"58","author":"Gross","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.chest.2019.04.093_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cid\/cir813","article-title":"Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department","volume":"54","author":"Shorr","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.chest.2019.04.093_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MAJ.0b013e318294833f","article-title":"Patterns of initial antibiotic therapy for community-acquired pneumonia in U.S. hospitals, 2000 to 2009","volume":"347","author":"Berger","year":"2014","journal-title":"Am J Med Sci"},{"issue":"9","key":"10.1016\/j.chest.2019.04.093_bib7","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/cid\/civ629","article-title":"Trends in antibiotic use and nosocomial pathogens in hospitalized veterans with pneumonia at 128 medical centers, 2006-2010","volume":"61","author":"Jones","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.chest.2019.04.093_bib8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/cid\/ciw300","article-title":"Staphylococcus aureus community-acquired pneumonia: prevalence, clinical characteristics, and outcomes","volume":"63","author":"Self","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.chest.2019.04.093_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00408-013-9462-8","article-title":"Guideline-concordant antimicrobial therapy for healthcare-associated pneumonia: a systematic review and meta-analysis","volume":"191","author":"Troitino","year":"2013","journal-title":"Lung"},{"issue":"4","key":"10.1016\/j.chest.2019.04.093_bib10","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1183\/09031936.00141110","article-title":"Guideline-concordant therapy and outcomes in healthcare-associated pneumonia","volume":"38","author":"Attridge","year":"2012","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2019.04.093_bib11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.annemergmed.2015.02.003","article-title":"Impact of an electronic clinical decision support tool for emergency department patients with pneumonia","volume":"66","author":"Dean","year":"2015","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.chest.2019.04.093_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(10)70314-5","article-title":"Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study","volume":"11","author":"Kett","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"suppl 3","key":"10.1016\/j.chest.2019.04.093_bib13","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1017\/S0899823X00194073","article-title":"Outcomes of patients with healthcare-associated pneumonia: worse disease or sicker patients?","volume":"35","author":"Rothberg","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"10.1016\/j.chest.2019.04.093_bib14","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/jac\/dku533","article-title":"Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia","volume":"70","author":"Rothberg","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.chest.2019.04.093_bib15","doi-asserted-by":"crossref","first-page":"886","DOI":"10.12788\/jhm.2877","article-title":"Treatment trends and outcomes in healthcare-associated pneumonia","volume":"12","author":"Haessler","year":"2017","journal-title":"J\u00a0Hosp Med"},{"issue":"1","key":"10.1016\/j.chest.2019.04.093_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1378\/chest.10-1296","article-title":"CURB-65 pneumonia severity assessment adapted for electronic decision support","volume":"140","author":"Jones","year":"2011","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chest.2019.04.093_bib17","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1128\/AAC.03071-15","article-title":"Derivation and multicenter validation of the drug resistance in pneumonia clinical prediction score","volume":"60","author":"Webb","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.chest.2019.04.093_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1513\/AnnalsATS.201506-368BC","article-title":"Use of tracheal aspirate culture in newly intubated patients with community-onset pneumonia","volume":"13","author":"McCauley","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.chest.2019.04.093_bib19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/AAC.01805-13","article-title":"Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia","volume":"58","author":"Dangerfield","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.chest.2019.04.093_bib20","unstructured":"CDC. Antimicrobial use and resistance (AUR) module. In: Control CfD, ed. Vol 14. Atlanta, GA; 2019:1-53. https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/11pscaurcurrent.pdf. Accessed June 4, 2019."},{"key":"10.1016\/j.chest.2019.04.093_bib21","series-title":"Using the longitudinal structure of earnings to estimate the effect of training programs. NBER Working Paper Series","author":"Ashenfelter","year":"1984"},{"key":"10.1016\/j.chest.2019.04.093_bib22","series-title":"Identification and inference in nonlinear difference-in-difference models. Technical Working Series","author":"Athey","year":"2002"},{"issue":"4","key":"10.1016\/j.chest.2019.04.093_bib23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.annemergmed.2018.10.007","article-title":"Emergency department crowding is associated with delayed antibiotics for sepsis","volume":"73","author":"Peltan","year":"2019","journal-title":"Ann Emerg Med"},{"issue":"suppl 2","key":"10.1016\/j.chest.2019.04.093_bib24","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.chest.2019.04.093_bib25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/resp.12560","article-title":"Accuracy of PaO2\/FiO2 calculated from SpO2 for severity assessment in ED patients with pneumonia","volume":"20","author":"Sanz","year":"2015","journal-title":"Respirology"},{"key":"10.1016\/j.chest.2019.04.093_bib26","unstructured":"Utah Department of Health. Utah influenza report. Salt Lake City, UT; 2015."},{"key":"10.1016\/j.chest.2019.04.093_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1345\/aph.1R322","article-title":"Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home","volume":"47","author":"Chen","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.chest.2019.04.093_bib28","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1532-5415.2009.02279.x","article-title":"Effect of antibiotic guidelines on outcomes of hospitalized patients with nursing home-acquired pneumonia","volume":"57","author":"El Solh","year":"2009","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.chest.2019.04.093_bib29","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1440-1843.2012.02306.x","article-title":"Health care-associated pneumonia in haemodialysis patients: clinical outcomes in patients treated with narrow versus broad spectrum antibiotic therapy","volume":"18","author":"Taylor","year":"2013","journal-title":"Respirology"},{"issue":"7","key":"10.1016\/j.chest.2019.04.093_bib30","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/phar.1442","article-title":"Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam","volume":"34","author":"Burgess","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"7","key":"10.1016\/j.chest.2019.04.093_bib31","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/phar.1428","article-title":"Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime","volume":"34","author":"Gomes","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.chest.2019.04.093_bib32","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.clinthera.2007.06.014","article-title":"A\u00a0retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia","volume":"29","author":"Jeffres","year":"2007","journal-title":"Clin Ther"},{"issue":"7","key":"10.1016\/j.chest.2019.04.093_bib33","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/phar.1423","article-title":"Vancomycin-associated nephrotoxicity in adult medicine patients: incidence, outcomes, and risk factors","volume":"34","author":"Meaney","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.chest.2019.04.093_bib34","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jac\/dkq038","article-title":"Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic","volume":"65","author":"Chalmers","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.chest.2019.04.093_bib35","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/cid\/cix947","article-title":"Risk of subsequent sepsis within 90\u00a0days after a hospital stay by type of antibiotic exposure","volume":"66","author":"Baggs","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.chest.2019.04.093_bib36","doi-asserted-by":"crossref","first-page":"c2096","DOI":"10.1136\/bmj.c2096","article-title":"Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis","volume":"340","author":"Costelloe","year":"2010","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.chest.2019.04.093_bib37","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1093\/jac\/dky202","article-title":"Outcomes associated with the use of a revised risk assessment strategy to predict antibiotic resistance in community-onset pneumonia: a stewardship perspective","volume":"73","author":"Farkas","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.chest.2019.04.093_bib38","author":"MDCalc"},{"issue":"5","key":"10.1016\/j.chest.2019.04.093_bib39","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1378\/chest.09-2175","article-title":"Why mortality is increased in health-care-associated pneumonia: lessons from pneumococcal bacteremic pneumonia","volume":"137","author":"Rello","year":"2010","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.chest.2019.04.093_bib40","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/rccm.201301-0079OC","article-title":"Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia","volume":"188","author":"Shindo","year":"2013","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369219310128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369219310128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:12:09Z","timestamp":1757923929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369219310128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0012369219310128"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2019.04.093","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic Use and Outcomes After Implementation of the Drug Resistance in Pneumonia Score in ED Patients With Community-Onset Pneumonia","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2019.04.093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}